Polar body array CGH for prediction of the status of the corresponding oocyte. Part I: clinical results.
about
Human aneuploidy: mechanisms and new insights into an age-old problemMethods for comprehensive chromosome screening of oocytes and embryos: capabilities, limitations, and evidence of validityThe clinical effectiveness of preimplantation genetic diagnosis for aneuploidy in all 24 chromosomes (PGD-A): systematic reviewMeiosis and maternal aging: insights from aneuploid oocytes and trisomy birthsThe ageing ovary and uterus: new biological insightsDynamics and ethics of comprehensive preimplantation genetic testing: a review of the challengesWhole-genome sequencing in health care. Recommendations of the European Society of Human Genetics.Selection of competent blastocysts for transfer by combining time-lapse monitoring and array CGH testing for patients undergoing preimplantation genetic screening: a prospective study with sibling oocytesMitogenomes of polar bodies and corresponding oocytes.Single cell segmental aneuploidy detection is compromised by S phasePolar body array CGH for prediction of the status of the corresponding oocyte. Part II: technical aspectsSingle-cell genome sequencing: current state of the science.OMICS: Current and future perspectives in reproductive medicine and technologyPolar body based aneuploidy screening is poorly predictive of embryo ploidy and reproductive potentialThe ESHRE PGD Consortium: 10 years of data collection.Delivery of a chromosomally normal child from an oocyte with reciprocal aneuploid polar bodies.Impact of whole-genome amplification on the reliability of pre-transfer cattle embryo breeding value estimates.Embryos of robertsonian translocation carriers exhibit a mitotic interchromosomal effect that enhances genetic instability during early developmentIdentification of chromosomal errors in human preimplantation embryos with oligonucleotide DNA microarray.Use of both cumulus cells' transcriptomic markers and zona pellucida birefringence to select developmentally competent oocytes in human assisted reproductive technologiesLive birth rates using conventional in vitro fertilization compared to intracytoplasmic sperm injection in Bologna poor responders with a single oocyte retrieved.Increasing live birth rate by preimplantation genetic screening of pooled polar bodies using array comparative genomic hybridizationPreimplantation Genetic Diagnosis: Prenatal Testing for Embryos Finally Achieving Its PotentialRandomized comparison of next-generation sequencing and array comparative genomic hybridization for preimplantation genetic screening: a pilot studyComparison of array comparative genomic hybridization and quantitative real-time PCR-based aneuploidy screening of blastocyst biopsiesThe Majority of Resorptions in Old Mice Are Euploid.Multiple meiotic errors caused by predivision of chromatids in women of advanced maternal age undergoing in vitro fertilisation.SNP array-based copy number and genotype analyses for preimplantation genetic diagnosis of human unbalanced translocations.Preimplantation genetic diagnosis for aneuploidy and translocations using array comparative genomic hybridization.Follicular fluid protein content (FSH, LH, PG4, E2 and AMH) and polar body aneuploidy.Embryos whose polar bodies contain isolated reciprocal chromosome aneuploidy are almost always euploidNon-meiotic chromosome instability in human immature oocytesPreimplantation genetic diagnosis guided by single-cell genomics.Comprehensive genetic assessment of the human embryo: can empiric application of microarray comparative genomic hybridization reduce multiple gestation rate by single fresh blastocyst transfer?Preimplantation genetic diagnosis: recent triumphs and remaining challenges.A methodological overview on molecular preimplantation genetic diagnosis and screening: a genomic future?Best practices of ASRM and ESHRE: a journey through reproductive medicine.Polar bodies in assisted reproductive technology: current progress and future perspectives.How should we choose the 'best' embryo? A commentary on behalf of the British Fertility Society and the Association of Clinical Embryologists.Targeting oocyte maturation to improve fertility in older women.
P2860
Q24631178-F9821162-227B-4677-BF1B-1A1B52889FFBQ26824853-15138054-75FD-4D05-B18E-4FC0EBD0635DQ26849761-E206B993-DE5D-40A7-A2BC-899ED6EDB63AQ28259795-C5D6891E-3A3F-43A4-B960-9FE6179C8115Q28278102-45B573E1-068B-4A5A-B4DB-22E76E309601Q28286723-FD435EFC-67F9-4936-8907-E39356BD9EDCQ30391597-61084436-8C91-4C91-96B3-A076A448B0F4Q33830129-AEAAB1C8-7D65-4F8D-8006-AF7D26A73449Q33916343-DD901E16-0B4D-4EDB-B20C-CE305869EF93Q33965232-ADFC75D3-F1AD-4A1E-8B0F-2C52D903C88FQ34015963-04EBC24C-7F1F-4764-A3AA-A16A9D52BE7FQ34045945-9CE8E932-FD42-430F-8F0F-8A4E7EECE88DQ34113055-088604CA-7A64-4E79-9D2A-06927F8883C1Q34145730-0B1EF5FC-064A-40E9-AC6E-43B7E0FA4DB3Q34161543-66BC184E-E51C-4CB9-AE0E-70AFB24C2DC2Q34264475-B75CC485-4985-4F23-B119-97C0F57516EFQ34363067-D09D5029-DA31-44CF-99E1-23825989A3EAQ34469044-F55AD87A-51B3-440C-9337-2B83B65DBD24Q34685236-200BF445-1EF3-4AAA-AB12-B0CC025AB4E3Q35042633-6376ABC6-433C-4AB8-A34B-DFF533C39D50Q35599517-9C32B497-1262-4961-AC61-20734CC6D5EEQ35665081-20ED90D9-508F-4E1B-AB1B-1047CF6A1A3CQ35667220-2A59800F-D06A-4700-9168-B654DCA56F9CQ35671340-0C1DF5E9-7135-41C7-B9AF-3CD4FDF5A6F6Q35722205-994C877F-C2DA-4976-BAE4-3E67236C7B12Q35860862-43C954E0-EFA0-4CBA-9ADB-DDC5A11562F5Q36035686-BABA9A43-524F-4A55-A716-9F62228109EDQ36170424-E2D155C7-557B-4B26-8E02-BBE40B184627Q36186429-F6008AF1-7C27-4FA8-A96A-C7E8F7707AF2Q36381621-3C59D228-3439-462A-90FE-7B2B108D658DQ36534703-AB18A226-CE31-4B9E-A470-84C7BE0DBCA8Q37493024-27004463-6D93-4ADD-B08C-D9825260EBFEQ37691155-67527971-9C7C-4A41-8F2B-61AFA5771F7AQ38017130-62FC009C-7111-442A-BC9C-DE83B057F3C6Q38030601-63B6783F-C121-41A4-909C-D19C9102BF8AQ38031577-A211CCE0-EEE7-496B-91D1-836DB66B0FCCQ38055459-78EEF589-416C-46BE-9BEC-47475AA64EF5Q38282802-6FD38BEA-D8AE-40D9-A669-E73CCF22427CQ38575047-C25356D7-CA04-471F-A022-8D0627F7FA7DQ38578383-2CE0AD40-00CE-41C9-A7C9-A40F3C07DDCF
P2860
Polar body array CGH for prediction of the status of the corresponding oocyte. Part I: clinical results.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Polar body array CGH for predi ...... yte. Part I: clinical results.
@ast
Polar body array CGH for predi ...... yte. Part I: clinical results.
@en
type
label
Polar body array CGH for predi ...... yte. Part I: clinical results.
@ast
Polar body array CGH for predi ...... yte. Part I: clinical results.
@en
prefLabel
Polar body array CGH for predi ...... yte. Part I: clinical results.
@ast
Polar body array CGH for predi ...... yte. Part I: clinical results.
@en
P2093
P2860
P356
P1433
P1476
Polar body array CGH for predi ...... yte. Part I: clinical results.
@en
P2093
Alan Handyside
Andreas Schmutzler
Catherine Staessen
Hans van der Ven
Joep Geraedts
John Collins
Joyce Harper
Katerina Vesela
Luca Gianaroli
M Cristina Magli
P2860
P304
P356
10.1093/HUMREP/DER294
P407
P577
2011-09-09T00:00:00Z